Previous 10 | Next 10 |
2023-06-23 15:22:26 ET As the end of the second quarter draws near, a range of notable companies are set to release their earnings reports next week. Leading the pack is Nike ( NYSE: NKE ), the footwear and sports apparel giant. Elsewhere, chip makers Micron Technology ( NASDA...
SEATTLE, June 13, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal first quarter 2024 financial results on Thursday, June 29, 2023, after the market closes. In conjunction, the company w...
Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner Ecosystem PR Newswire Accolade and Equip offer employers purpose-built integrations to address barriers to eating disorder treatment. SEATTLE , June 7, 2023 /PRNewswire/ -- Acc...
Report: Employees are Overwhelmed, Delaying Care at High Rates PR Newswire New health trends report explores causes of stress and offers solutions, including virtual care expansion and enhanced health equity. SEATTLE , June 5, 2023 /PRNewswire/ -- Accolad...
SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stifel 2023 Cross Sector Insight Conference in Boston on Tuesday, June 6, 2023 at 11:30 am ET. A webcast of the e...
2023-05-27 10:24:40 ET Summary ACCD has experienced high demand, with revenue increasing by 5.6% in 4Q23 and a 33% increase in ARR bookings. During the analyst day, ACCD upgraded its FY25 margin target and expressed confidence in reaching $500 million in sales. ACCD's custom-b...
2023-05-24 17:32:31 ET Gainers: NVIDIA Corporation ( NVDA ) +22% . GSI Technology ( GSIT ) +16% . Nutanix ( NTNX ) +14% . Applied Digital ( APLD ) +12% . VNET Group ( VNET ) +10% . Losers: QuantaSing Group ( ...
2023-05-24 13:08:11 ET Accolade, Inc. ( NASDAQ: ACCD ) shares spiked Wednesday after Bank of America upgraded the IT-led healthcare services company to Buy from Neutral, arguing that its recent earnings-led selloff and post-analyst day weakness was overdone. Seattle, Washington-...
SEATTLE, May 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming investor events. A webcast and replay of each event will be available at ir.accolade.com. ...
2023-05-06 10:15:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...